Maintenance therapy after allogeneic stem cell transplantation for relapse prevention in myeloid malignancies.
PURPOSE OF REVIEW Relapse remains the leading cause of treatment failure after allogeneic hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and outcomes after relapse are poor. This review summarizes and critically appraises current evidence for post-HCT main...